Analysis of the therapeutic effect of thin-walled low-chronic outward force stent in the treatment of femoral popliteal artery occlusive disease / 中国医师杂志

ABSTRACT

Objective:To analyze the clinical effect of thin-walled low-chronic outward force (COF) stent in the treatment of femoral popliteal artery occlusive disease.Methods:Retrospective analysis was made on the clinical data of 76 consecutive patients with femoral popliteal artery occlusive disease (76 limbs) of lower extremities admitted to Renji Hospital affiliated to Shanghai Jiaotong University Medical College from June 2018 to May 2019, all of whom underwent Pulsar-18 stent(Biotronic, Germany) implantation. The clinical symptoms and stent patency rate were analyzed.Results:All 76 patients were successfully implanted with stents, and the Rutherford grade of postoperative clinical symptoms was significantly decreased, while the ankle brachial index (ABI) was significantly increased ( P<0.05). After 24 months of follow-up, the patency rates of femoral popliteal artery stents in phase Ⅰ at 3, 6, 12 and 24 months were 97.0%(64/66), 95.4%(62/65), 82.8%(53/64) and 79.4%(50/63), respectively. The patency rates of femoral popliteal artery stents in phase Ⅱ at 6, 12 and 24 months were 100%(65/65), 95.3%(61/64) and 90.5%(57/63), respectively. The stent patency rate was lower in complex femoral popliteal artery occlusion. Conclusions:The thin-walled and low-COF stent has good clinical results and patency in treatment of femoral popliteal artery occlusive disease. Good vessel prepare and drug-coated balloon may lower the in-stent restenosis.